Wave Life Sciences Ltd.
WVE
Get informed when a big investor buys or sells
+ FollowMarket Cap$993.12M
Close$
$0.29
94.1% downside
Current Fair Value
94.1% downsideOvervalued by 94.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $993.12 Million |
|---|---|
| Enterprise Value | $677.41 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.21 |
| Beta | -1.29 |
| Outstanding Shares | 202,098,901 |
Return
| Return on Equity | -44.64% |
|---|---|
| Return on Assets | -35.85% |
| Return on Invested Capital | -42.92% |
Valuation & Multiples
| P/E Ratio | -4.62 |
|---|---|
| PEG | -12.36 |
| Price to Sales | - |
| Price to Book Ratio | 2.44 |
| Enterprise Value to Revenue | 10.36 |
| Enterprise Value to EBIT | -3.2 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.12 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 30, 2026
EPS Estimate
$-0.30
Average shareholder expectationRevenue Estimate
$7.45 M
Average shareholder expectationNext Earnings Call
Expected Date
November 9, 2026
EPS Estimate
$-0.33
Average shareholder expectationRevenue Estimate
$5.03 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.4669▲ 15.22% |
|---|---|
| Total Calls | 426,000▼ 88.37% |
| Total Puts | 198,900▼ 82.74% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 91.96%▼ 3.93% |
|---|---|
| Total Invested | $1.21B▼ 3.68% |
| Investors Holding | 250▼ 5.00% |
ESG Score
No data
About Wave Life Sciences Ltd.
CEO: Paul Bolno